Prohibitins in infection: potential therapeutic targets.

IF 2.4 4区 生物学 Q3 MICROBIOLOGY Future microbiology Pub Date : 2025-03-01 Epub Date: 2025-01-29 DOI:10.1080/17460913.2025.2459530
Nuo Chen, Xiaolan Liu, Lulu Wang, Hui Yu, Fangqian Liu, Mengran Yuan, Qimeng Wang, Tianyi Zhang, Xiaoxiang Zhou, Hua Wang, Zengjun Ji, Hongxing Shen
{"title":"Prohibitins in infection: potential therapeutic targets.","authors":"Nuo Chen, Xiaolan Liu, Lulu Wang, Hui Yu, Fangqian Liu, Mengran Yuan, Qimeng Wang, Tianyi Zhang, Xiaoxiang Zhou, Hua Wang, Zengjun Ji, Hongxing Shen","doi":"10.1080/17460913.2025.2459530","DOIUrl":null,"url":null,"abstract":"<p><p>Prohibitins (PHBs) are members of a highly conserved family of proteins, including prohibitin1 and prohibitin2. These proteins are predominantly localized in mitochondria, the nucleus, and cell membranes, where they play critical roles in mitochondrial biogenesis, apoptosis, immune regulation, and other biological processes. Recent studies have demonstrated that both PHB1 and PHB2 can act as a complex or independently to participate in the pathogen infection process. This review focuses on the regulatory roles of PHB1 and PHB2 in viral, bacterial, parasitic and fungal infections, providing a theoretical basis and innovative perspectives for a comprehensive understanding of the roles and mechanisms of PHB1 and PHB2 in the regulation of microbial infections. Due to exerting multiple functions, PHB proteins have been recognized as a potential target for therapeutic interventions, with the expectation that targeting PHB proteins will provide new strategies for the treatment of infection-related diseases.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":" ","pages":"345-355"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11938962/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1080/17460913.2025.2459530","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Prohibitins (PHBs) are members of a highly conserved family of proteins, including prohibitin1 and prohibitin2. These proteins are predominantly localized in mitochondria, the nucleus, and cell membranes, where they play critical roles in mitochondrial biogenesis, apoptosis, immune regulation, and other biological processes. Recent studies have demonstrated that both PHB1 and PHB2 can act as a complex or independently to participate in the pathogen infection process. This review focuses on the regulatory roles of PHB1 and PHB2 in viral, bacterial, parasitic and fungal infections, providing a theoretical basis and innovative perspectives for a comprehensive understanding of the roles and mechanisms of PHB1 and PHB2 in the regulation of microbial infections. Due to exerting multiple functions, PHB proteins have been recognized as a potential target for therapeutic interventions, with the expectation that targeting PHB proteins will provide new strategies for the treatment of infection-related diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
感染禁止药:潜在的治疗靶点。
prohibition (PHBs)是一个高度保守的蛋白家族的成员,包括prohibitin1和prohibitin2。这些蛋白主要分布在线粒体、细胞核和细胞膜中,在线粒体生物发生、细胞凋亡、免疫调节和其他生物过程中起着关键作用。最近的研究表明,PHB1和PHB2都可以作为复合物或独立参与病原体感染过程。本文综述了PHB1和PHB2在病毒、细菌、寄生虫和真菌感染中的调控作用,为全面了解PHB1和PHB2在微生物感染调控中的作用和机制提供理论基础和创新视角。由于具有多种功能,PHB蛋白已被认为是治疗干预的潜在靶点,预计靶向PHB蛋白将为感染相关疾病的治疗提供新的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future microbiology
Future microbiology 生物-微生物学
CiteScore
4.90
自引率
3.20%
发文量
134
审稿时长
6-12 weeks
期刊介绍: Future Microbiology delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this increasingly important and vast area of research.
期刊最新文献
Author response to commentary on oral microbiota analysis in HPV-infected individuals: considerations for future research. Strategic use of microbial culture collections to empower drug discovery. Usnic acid chitosan-coated liposomes synergistic activity with polymyxin B against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical in vitro. Synthesis and characterization of ZnO:CuO nanoparticles and evaluation of their antibacterial activity. Mutation, biofilm formation, and cell wall remodeling contribute to echinocandin resistance of Candidozyma auris.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1